Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Hims & Hers

Hims & Hers Data Shows Personalized GLP-1 Plans Drive Real Weight Loss, Few Side Effects, and Strong Adherence to Care
From Hims & Hers
Via Business Wire
Tickers HIMS
Hims & Hers to Announce Second Quarter 2025 Financial Results on August 4, 2025
From Hims & Hers
Via Business Wire
Tickers HIMS
Hims & Hers Announces Planned 2026 Expansion to Canada, Following ZAVA Acquisition Completion
From Hims & Hers
Via Business Wire
Tickers HIMS
Hims & Hers Announces Plans to Acquire ZAVA, Accelerating Major European Growth Across the UK, Germany, France, and Ireland
From Hims & Hers
Via Business Wire
Tickers HIMS
Hims & Hers Introduces 6-Month Wegovy® New Customer Offer
From Hims & Hers
Via Business Wire
Tickers HIMS
Hims & Hers Health, Inc. Prices Upsized $870.0 Million Convertible Senior Notes Offering to Accelerate Global Expansion and Utilization of AI in Healthcare
From Hims & Hers
Via Business Wire
Tickers HIMS
Hims & Hers Health, Inc. Announces Proposed Convertible Senior Notes Offering to Accelerate Global Expansion and Utilization of AI in Healthcare
From Hims & Hers
Via Business Wire
Tickers HIMS
Hims & Hers Appoints AI Expert and Former President and CTO at Cruise as Chief Technology Officer
From Hims & Hers
Via Business Wire
Tickers HIMS
Hims & Hers Health, Inc. Reports First Quarter 2025 Financial Results
From Hims & Hers
Via Business Wire
Tickers HIMS
Hims & Hers Appoints Global Operations Expert and Amazon Veteran as Chief Operations Officer
From Hims & Hers
Via Business Wire
Tickers HIMS
Hims & Hers and Novo Nordisk Team Up to Expand Affordable Access to Care
From Hims & Hers
Via Business Wire
Tickers HIMS
Hims & Hers to Announce First Quarter 2025 Financial Results on May 5, 2025
From Hims & Hers
Via Business Wire
Tickers HIMS
Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
From Hims & Hers
Via Business Wire
Tickers HIMS
Hims & Hers Acquires US-based Peptide Facility
From Hims & Hers
Via Business Wire
Tickers HIMS
Hims & Hers Acquires At-Home Lab Testing Facility, Expanding Capabilities to Ultimately Include Affordable Whole Body Testing for Subscribers
From Hims & Hers
Via Business Wire
Tickers HIMS
Hims & Hers Launches Health Collective and Community Member Council
From Hims & Hers
Via Business Wire
Tickers HIMS
Hims & Hers to Announce Fourth Quarter and Full Year 2024 Financial Results on February 24, 2025
From Hims & Hers
Via Business Wire
Tickers HIMS
The Shape of America 2024: Hims & Hers Shares an In-Depth Look Into How Americans Feel About Weight
From Hims & Hers
Via Business Wire
Tickers HIMS
Hims & Hers Named to Inc.’s 2024 Best in Business List in Health Products Category
From Hims & Hers
Via Business Wire
Tickers HIMS
Hims & Hers Expands Nutrition Support to Fuel Customers’ Weight Loss Journeys
From Hims & Hers
Via Business Wire
Tickers HIMS
Hims & Hers Appoints Tenured Pharmaceutical, Regulatory, and Quality Experts to Key Leadership Positions
From Hims & Hers
Via Business Wire
Tickers HIMS
Americans Continue to Struggle to Access Branded GLP-1s as Shortages Continue
From Hims & Hers
Via Business Wire
Tickers HIMS
Hims & Hers Health, Inc. Reports Third Quarter 2024 Financial Results
From Hims & Hers
Via Business Wire
Tickers HIMS
How Compounded Treatments Are Helping Hims & Hers Customers Meet Their Weight Loss Goals
From Hims & Hers
Via Business Wire
Tickers HIMS
Hims & Hers names Dr. Jessica Shepherd as Chief Medical Officer of Hers
From Hims & Hers
Via Business Wire
Tickers HIMS
Hims & Hers to Announce Third Quarter 2024 Financial Results on November 4, 2024
From Hims & Hers
Via Business Wire
Tickers HIMS
Hims & Hers to Offer Access to Compounded GLP-1 Injections for as Low as $99/Month to U.S. Military, Veterans, Teachers, Nurses and First Responders
From Hims & Hers
Via Business Wire
Tickers HIMS
Hims & Hers Health, Inc. Reports Second Quarter 2024 Financial Results
From Hims & Hers
Via Business Wire
Tickers HIMS
Pharmaceutical Industry Chief Kåre Schultz Joins Hims & Hers Board
From Hims & Hers
Via Business Wire
Tickers HIMS
Hims & Hers to Announce Second Quarter 2024 Financial Results on August 5, 2024
From Hims & Hers
Via Business Wire
Tickers HIMS
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.